Press Releases

For press releases issued prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Date Title  
07/28/15
DUBLIN, IRELAND -- (Marketwired) -- 07/28/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the period ended June 30, 2015 after market close on Monday, August 10, 2015 .
07/23/15

Latest Approval Expands Product Label in Canada and Further Strengthens Global Brand for Once-Daily, Dual Mechanism Antibiotic

07/02/15
DUBLIN, IRELAND -- (Marketwired) -- 07/02/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that stock options to purchase an aggregate of 113,900 of the Company's ordinary shares were granted to twenty new non-executive officer employees on
06/30/15

Regulatory Approval Is Significant Achievement in Building the Global Brand for Once-Daily, Dual Mechanism Antibiotic

06/02/15
GEORGE TOWN, GRAND CAYMAN -- ( Marketwired ) -- 06/02/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that stock options to purchase an aggregate of 27,000 of the Company's ordinary shares were granted to eight new non-executive officer
05/27/15

Once-Daily, Dual Mechanism Antibiotic Possesses Profile to Play Key Role in Global Fight Against Antimicrobial Resistance

05/20/15

Findings Support Potential for First Once-Daily Nebulized LAMA in COPD; Initiation of Phase 3 Registrational Trials Planned for 2015

05/18/15

Velusetrag Improved Gastric Emptying Time Across All Doses vs. Placebo; Velusetrag Produced a Clinically Meaningful Improvement in Gastric Emptying Time in Both Diabetic and Idiopathic Gastroparetic Patients

05/07/15

VIBATIV(R) Commercial Activities Gaining Momentum; TD-4208 Phase 3 Program to Commence Second Half 2015; New Product Candidates Advancing Towards the Clinic; Lowering Operating Loss Guidance for 2015

05/04/15
GEORGE TOWN, GRAND CAYMAN -- ( Marketwired ) -- 05/04/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that stock options to purchase an aggregate of 7,900 of the Company's ordinary shares were granted to four new non-executive officer